PAR DRUGS AND CHEM LTD Share Price

PAR DRUGS AND CHEM LTD Share Price

NSE: PAR
|
Chemicals
|
S Cap
₹ 141.70
+₹0.62 (0.44%)
1D
Last updated 11 Sep, 2026, 15:29 IST

PAR DRUGS AND CHEM LTD Share Price Today

As of 13 Sep 2026, PAR DRUGS AND CHEM LTD share price is ₹141.70. The stock opened at ₹141.99, compared to its previous close of ₹141.08. During today's trading session, PAR DRUGS AND CHEM LTD share price moved in the range of ₹134.03 to ₹147.96, with an average price of ₹141.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹78.05 and a high of ₹180.00. On the performance front, PAR DRUGS AND CHEM LTD share price has increased by 56.07% over the last six months and is up 24.08% on a year-on-year basis.

₹134.03
0.44% up today
₹147.96
1D LOW
1D HIGH

PAR DRUGS AND CHEM LTD Returns Calculator

Circuit
L
H
₹133.88
₹147.96
52-week
L
H
₹78.05
₹180.00

About PAR DRUGS AND CHEM LTD

PAR DRUGS AND CHEM LTD Share Price
ISIN
INE04LG01015
Sector Market Cap
₹ 173.40 Cr

Par Drugs and Chemicals Limited is an India-based company engaged in manufacturing of active pharma ingredients (APIs) and fine chemicals for the domestic market as well as for exports to international markets. The Company manufactures a diverse range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide, and sucralfate USP. The Company owns and operates its manufacturing facilities at Bhavnagar in Gujarat. It has over four manufacturing blocks at Bhavnagar, which are for different products, having a capacity of approximately 9,700 metric tons per annum.

PAR DRUGS AND CHEM LTD Financial Highlights

  • Revenue: PAR DRUGS AND CHEM LTD reported revenue of ₹107.66 crore in FY26 vs ₹103.12 crore in FY25. It showed an increase of 4.40% on a yearly basis.
  • Operating Profit: PAR DRUGS AND CHEM LTD reported an operating profit of ₹17.30 crore in FY26 vs ₹17.92 crore in FY25. It showed a decrease of 3.46% on a year-on-year basis.
  • Net Profit: PAR DRUGS AND CHEM LTD reported a net profit of ₹13.11 crore in FY26 vs ₹13.36 crore in FY25. It showed a decrease of 1.87% on a yearly basis.

PAR DRUGS AND CHEM LTD Quarterly Result Highlights

  • PAR DRUGS AND CHEM LTD reported revenue of ₹32.22 crore in Jun 2026, compared with ₹19.97 crore in Mar 2026, representing an increase of 61.34% on a quarter-on-quarter (QoQ) basis.
  • PAR DRUGS AND CHEM LTD reported an operating profit of ₹6.33 crore in Jun 2026, compared with ₹0.83 crore in Mar 2026, representing an increase of 662.65% on a quarter-on-quarter (QoQ) basis.
  • PAR DRUGS AND CHEM LTD reported a profit of ₹4.71 crore in Jun 2026, compared with ₹0.85 crore in Mar 2026, reflecting an increase of 454.12% on a QoQ basis.
  • The earnings per share (EPS) of PAR DRUGS AND CHEM LTD stood at ₹10.65 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
73.41%
FII
0.00%
Other DII
0.09%
Retail and other
26.51%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
173.40
P/E
11.96
P/B
1.55
ROE
11.71%
D/E
0.00
ROCE
15.56%
Div. Yield
0.00%
EPS(TTM)
10.65
Turnover
0.84
EV/EBITDA
5.70
Net Margin
9.03%
Op. Margin
16.39%
ROA
11.21%
Quick Ratio
4.29
Curr. Ratio
4.68
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Par Drugs & Che. outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Par Drugs & Che. appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,41,958.0036.485.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,47,576.0084.6414.7715.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,233.0087.7722.5025.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,11,671.0024.324.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,273.0032.863.2011.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,06,460.0097.6420.0916.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories96,906.4030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma96,401.7025.982.549.25%0.1911.76%394.820.24%0.3841.58
Lupin95,842.9017.274.2723.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma94,050.4045.495.7711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

PAR DRUGS AND CHEM LTD Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹103.66₹100.97₹95.64₹95.75
Other Income₹4.00₹2.15₹0.24₹0.24
Total Revenue₹107.66₹103.12₹95.88₹95.99
Total Expenses₹90.35₹85.20₹76.37₹80.91
Profit Before Tax₹17.30₹17.92₹19.52₹15.08
Tax₹4.19₹4.57₹5.02₹3.75
Profit After Tax₹13.11₹13.36₹14.50₹11.33
EPS - Basic₹10.65₹10.86₹11.78₹9.21
EPS - Diluted₹10.65₹10.86₹11.78₹9.21

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹17.30₹17.92₹19.52₹15.08
Income before WC changes₹19.06₹20.51₹22.61₹18.10
Change in Assets₹5.25-₹4.68₹4.87₹1.12
Change in Liabilities-₹2.86₹4.85-₹2.87-₹1.58
Change in WC₹2.40₹0.17₹2.00-₹0.46
Cash flow from Operations₹16.43₹16.16₹20.25₹13.38
Cash flow from Investing-₹2.17-₹25.24-₹5.84-₹7.34
Cash flow from Financing₹0.00₹0.00₹0.00₹0.00
Total Cash Flow₹14.27-₹9.08₹14.41₹6.04
Cash (Start of the year)₹27.58₹36.65₹22.24₹16.21
Cash (End of the year)₹41.84₹27.58₹36.65₹22.24

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹64.89₹64.53₹41.99₹39.43
Current Assets₹64.33₹54.86₹59.62₹49.44
Total Assets₹129.21₹119.39₹101.61₹88.87
Current Liabilities₹13.74₹16.57₹12.44₹13.99
Net Current Asset₹50.58₹38.29₹47.18₹35.45
Non-Current Liabilities₹3.48₹3.85₹3.54₹3.64
Equity Capital₹111.98₹98.97₹85.63₹71.24
Total Equity & Liabilities₹129.21₹119.39₹101.61₹88.87
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
140.92
1
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 1
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
61.77
Neutral
ATR (14)
11.97
Neutral
STOCH(9,6)
36.43
Neutral
STOCH RSI (14)
28.74
Neutral
ADX(9)
49.49
Bearish
UO(9)
45.56
Neutral
ROC(12)
41.57
Bullish
WillR(14)
-47.67
Neutral
Period
Simple value
Exponential vaue
5D
141.34
141.58
10D
145.46
138.28
20D
123.14
128.47
50D
107.56
113.26
100D
98.95
104.54
Volume trend — traded volume by day
11 Sep0L
10 Sep0L
9 Sep0L
8 Sep0L
7 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
PAR DRUGS AND CHEM LTD Share Price
PAR DRUGS AND CHEM LTD
Chemicals
Add Stock
Add Another

PAR DRUGS AND CHEM LTD Share Price FAQs

PAR DRUGS AND CHEM LTD share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837